nasal spray

Glenmark and Lotus enter into partnership for Ryaltris in key South East Asian markets

Read more

Glenmark gets US FDA nod for nasal spray to treat seasonal allergic rhinitis

Read more

Glenmark receives marketing approval for its nasal spray in 13 countries across EU and UK

Read more

Glenmark’s Ryaltris nasal spray gets approval in Europe for treatment of allergic rhinitis

Read more

Glenmark, Bausch Health partner to commercialise RYALTRIS nasal spray in Canada 

Read more

Glenmark gets marketing approval for Ryaltris, single nasal spray in Russia

Read more

China approves Phase I study of COVID-19 vaccine administered by nasal spray

Read more

US FDA approves SPRAVATO, antidepressant medication from J&J

Read more